Meridian Bioscience, Inc. (VIVO) Misses Q2 EPS by 2c, Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 2.72 +0.09 (3.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.63 | 52 Week High | $21.49 | |||
| Open | $2.69 | 52 Week Low | $15.75 | |||
| Day High | $2.72 | P/E | 3.09 | |||
| Day Low | $2.63 | EPS | $0.88 | |||
| Volume | 48,582 | |||||
